Could something called "Magic Swizzle" be harmful? We talked with Dr. Ricardo Nieves about his winning vignette on the topic. More
Could something called "Magic Swizzle" be harmful? We talked with Dr. Ricardo Nieves about his winning vignette on the topic. More
A randomized controlled trial in NEJM finds that inducing labor reduced the rate of c-sections and hypertensive disorder. Does this mean we should induce labor in all healthy women at 39 weeks? It's not that simple. More
Hospitals are developing the "check-up of the future" - but is it good for patients? More
How can we help the dental profession reduce unnecessary care? The answer lies in the power of patients. More
When does a cavity "need" filling? It depends on where your dentist lies on the spectrum of changing ideas in dentistry. More
But how do we define overdiagnosis, and what makes it different from other screening harms such as false positives or overtreatment? More
An industry-backed advocacy group argues that insurance should cover proton beam therapy for cancer patients. But there's no evidence the new treatment is better for most cancers... More
If stents for stable angina don't work, what else doesn't work? As it turns out, arthroscopic surgery for shoulder pain... More
The ORBITA debate continues as the study authors respond to critical letters in The Lancet. More
The number of children getting their tonsils out still varies based on physician opinion and patient demand. But a new study is changing the risk-benefit calculation... More
A small but growing group of primary care doctors are saying, "no more" to EHR requirements, useless quality measures, and indecipherable bills. More
Cancer advocacy groups are cheering the new screening guidelines for colorectal cancer, but few reports have examined both the costs and benefits of lowering the age of screening. More
Catheter ablation for atrial fibrillation has been used for 20 years, and grown into a $4.5 billion industry. But is the procedure actually effective? More
American women are still getting too many mammograms. Despite recommendations from the US Preventive Services Task Force and the American Cancer Society against routine screening for breast cancer before age 50, the rates of mammogram screening have not changed significantly in the past ten years. In a recent JAMA Clinical Update, Dr. Nancy Keating and […] More
For Randi Oster, the hardest part of her father's cancer wasn't getting him through treatment. It was getting his doctors to listen to what he wanted. More
When it comes to measuring quality, there is a huge disconnect between payers and physicians. A recent analysis in the New England Journal of Medicine lends support to the physicians' side of the issue. More
Gina Kolata misrepresents the debate on tPA for strokes by painting the issue as evidence versus belief. More
A study in The BMJ shows that overdiagnosis research is growing but discrepancies in definitions and measurement complicate the evidence. More
Not only does too much cancer screening lead to false positives and overtreatment, it can also skew our data. More